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The recent study "Local Association Between Endothelial Dysfunction and Intimal Hyperplasia: 
Relevance in Peripheral Artery Disease" assessed endothelial function, using flow-mediated 
dilation (FMD), in the legs (superficial femoral artery) and arms (brachial artery) of patients 
with peripheral arterial disease (PAD).1 The authors concluded that endothelial function was 
not impaired in the arms, but was reduced in the legs of PAD patients compared to age-
matched controls. While the article supports previous research suggesting that the brachial 
artery may not provide a global index of endothelial health for all populations, including those 
with spinal cord injury,2 it is contrary to two previous PAD studies reporting reduced brachial 
FMD.3, 4 This publication is particularly timely as the clinical relevance of FMD has recently 
come under attack for reasons such as poor measurement reliability, lack of appropriate 
covariate analysis, concerns over expressing FMD as a ratio 5, and improper normalization to 
the FMD stimulus.5 We suggest each of these concerns are highlighted in this study.  
First, with the between-day coefficient of variation for the standard brachial FMD test being as 
high as 50%,6 no mention of power analysis or variance estimates and small group sizes 
(n=10), the analyses potentially suffer from a lack of statistical power. Second, FMD was 
expressed as ratio, which can result in mathematical error propagation and allometric scaling 
issues.5 FMD should be expressed as the absolute change score, using baseline diameter and 
shear stress as covariates.5, 7 Last and perhaps most important, FMD can only be assessed if 
reactive hyperemia induces a sufficient shear stress stimulus to activate the endothelial cells, 
which may be prevented by an obstructed arterial lumen in PAD. In addition, an obstructed 
arterial lumen would induce a non-laminar flow profile, thereby invalidating one of the 
assumptions of Poiseuille's Law- based shear stress calculations.  
Because of these issues, the published findings should be interpreted with caution. While we 
commend the authors on conducting important work in this field, we suggest additional 
studies are required to elucidate whether FMD in the lower limbs is a true marker of 
endothelial function in patients with PAD.  
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